Since the Human Genome Project, the world of health care and medical intervention has rapidly been transformed into the genomic era, where the number of genetic interventions and tests are increasing at an alarming rate. Genetic testing is seen everywhere in health care, but most of the time physicians have to order the tests for their patients. Today however, consumers can go online and buy genetic tests themselves.Direct-to-consumer (DTC) genetic testing refers to genetic tests that are marketed and sold directly to individuals through the internet, television, or mail. Interpreting test results can be complex, and many times these concepts are not adequately discussed. Since this type of testing is still premature, many areas need to be analyzed in order to see the value or harm in this technology. Some of the risks with this type of testing include inappropriate test utilization, misinterpretation of results, and a lack of necessary follow-up. Dr. Robert Marion, a clinical geneticist, says that “without careful explanation, without accompanying genetic counseling to explain their meaning, the results are not only meaningless, they can actually be harmful.” The advocates for DTC genetic testing say that this will help with consumer empowerment, genetic privacy, and future treatment plans. This presentation will look at the science behind DTC genetic testing, identify the ethical issues, address the risks and benefits, and then discuss the implications this testing has on the future of health care.